ClinicalTrials.gg
RecruitingNCT03798158DyHPUpdated Jul 23, 2021

Prevalence and Characterization of Persistent Dyspnea After Hospitalization

An observational study in Dyspnea and Pulmonary Disease, sponsored by Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-07-23.

Sponsored by Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil · Observational

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 6 months ago, but the record still lists the study as recruiting.
  • Started Apr 2019; still recruiting 7 years 7 months later.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
150
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 10 studies in Dyspnea by Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil — 1 open to participants now, 1 under way, none of them phase 3. Dyspnea · Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil.

Started
2019
with 1 other
Observational
4 of 10
1 open now
Registered
6th of 10
by date

Among the 10 studies in Dyspnea by Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil, this one is one of 2 that started in 2019, is one of 4 observational ones, and was the 6th registered.

By phase

10 studies; the count open now beside each. This study's row is marked.

No phase6 · 0 open
Observationalthis study4 · 1 open

By the year they started

First in 2016; this study’s year is marked. 2 started in 2019.

What they test

Size and results

Median enrollment 33 across the 6 interventional studies, 20 across the 4 observational. Of the 7 that completed or were terminated, 0 (0%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 10 studies in Dyspnea by Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil, or all of them as a file.
02

Study summary

The investigators aim to make an overview of persistent dyspnea at the end of an hospitalization for a respiratory disease using an actual tool, the Multidisciplinary Dyspnea Profile questionnaire.

03

Conditions studied

  • Dyspnea
  • Pulmonary Disease
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Every consecutive patient admitted to hospitalization for a respiratory cause having a significant dyspnea

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age over 18 years old
  • Able to respond the questionnaire
  • Presenting at admission a dyspnea over 3/10 on numerical analogic scale
  • Admitted for a respiratory cause

Exclusion criteria

Exclusion Criteria:

  • cognitive impairment
  • aphasia
  • no french-speaking person
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No

Interventions

  • OtherMultidisciplinary Dyspnea Profile questionnaire

    Multidisciplinary Dyspnea Profile questionnaire at the beginning and the end of an hospitalization

06

What researchers measure

Primary outcomes

  1. Prevalence of persistent dyspnea in the end of an hospitalization for a a respiratory disease

    Time frame: An average of one week, until the end of the hospitalization

Secondary outcomes

  1. Characterization of persistent dyspnea using MDP

    Time frame: An average of one week, until the end of the hospitalization

  2. Outcome of patients with persistent dyspnea after hospitalization

    6 months mortality, incidence of rehospitalization

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • ADOREPS
    Paris, 75013, France
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2019 (actual). Primary completion is estimated for Apr 2025, 72 months after the start.

Of 116 non-industry observational studies under Dyspnea, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 47. This study's planned 72 months is above that.

Counting every sponsor, half of 125 studies reached it within 24 months; a quarter within 11 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 21, 2018
First posted
Jan 9, 2019
StartActual
Apr 11, 2019
Primary completionEst.
Apr 30, 2025
CompletionEst.
Apr 30, 2025
Last update
Jul 23, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 23, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03798158
Lead sponsor
Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil
Responsible party
Sponsor
First posted
Jan 9, 2019
Start date
Apr 11, 2019
Primary completion
Apr 30, 2025 (estimated)
Completion
Apr 30, 2025 (estimated)
Last update
Jul 23, 2021

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion